Evidence map›Paper›PMID 15200236›Full record

ArticleGene expression2004

Beta-catenin associates with human parainfluenza virus type 3 ribonucleoprotein complex and activates transcription of viral genome RNA in vitro.

Santanu Bose, Amiya K Banerjee

Open access · hybridAbstract read
In one paragraph

Article in Gene expression, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Target analysis of the experimental measles therapeutic AS-136A.Antimicrobial agents and chemotherapy · 2009
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Santanu BoseDepartment of Virology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. boses@ccf.org
Amiya K Banerjee
Cleveland Clinic · US

Funding

HOST/VIRUS INTERACTION AND GENE EXPRESSIONR01AI032027 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI BANERJEE, AMIYA K. · 1992 to 2006
$2.5M
NIAID NIH HHS AI32027NIAID NIH HHS R01 AI032027
6 · The paper itself

Abstract

Several studies have indicated that human parainfluenza virus type 3 (HPIV-3) requires polymeric actin for transcription of its genome RNA in vitro and in vivo. In the current study, we have identified beta-catenin, an actin-bound protein, as one of the transcriptional activators for HPIV-3 genome RNA. Beta-catenin was packaged within the purified HPIV-3 virions and was associated with the HPIV-3 ribonucleoproteins (RNP) from infected cells. Moreover, purified beta-catenin interacted with bacterially expressed HPIV-3 nucleocapsid protein (N) and phosphoprotein (P) fused to glutathione S-transferase (GST). Double-labeled immunofluorescent confocal microscopic analysis revealed colocalization of beta-catenin with HPIV-3 RNP at cell periphery in infected cells. The HPIV-3 RNP-associated beta-catenin functioned as a transactivator of HPIV-3 genome, because purified beta-catenin stimulated transcription of viral RNP in an in vitro transcription assay. These results demonstrate that beta-catenin, a multifunctional protein that is involved in cell-cell adhesion and embryogenesis, acts as one of the transcriptional activators of HPIV-3 genome RNA.

Indexed as

Gene Expression Regulation, Viralbeta CateninCytoskeletal ProteinsGenome, ViralHumansParainfluenza Virus 3, HumanProtein BindingRibonucleoproteinsRNA, ViralTrans-ActivatorsTranscriptional Activationbeta CateninCTNNB1 protein, humanCytoskeletal ProteinsRibonucleoproteinsRNA, ViralTrans-Activators

Identifiers

PMID15200236
PMCPMC5991151
OpenAlexW2088824751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.